Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 25949-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- CSF1R antibody
- Antibody type
- Polyclonal
- Description
- CSF1R antibody (Cat. #25949-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas.
Microglial targeted therapy relieves cognitive impairment caused by Cntnap4 deficiency.
Inhibition of inflammation and infiltration of M2 macrophages in NSCLC through the ATF3/CSF1 axis: Role of miR-27a-3p.
Human placenta-based genome-wide mRNA sequencing to identify TEK/IGF1/CSF1/ANGPT2 as crucial segments in the pathogenesis of pre-eclampsia.
Polarization and β-Glucan Reprogram Immunomodulatory Metabolism in Human Macrophages and Ex Vivo in Human Lung Cancer Tissues.
A novel chemokine-based signature for prediction of prognosis and therapeutic response in glioma.
Targeting CSF1R Alone or in Combination with PD1 in Experimental Glioma.
Integrating transcriptome-wide study and mRNA expression profiles yields novel insights into the biological mechanism of chondropathies.
Blanco-Carmona E, Narayanan A, Hernandez I, Nieto JC, Elosua-Bayes M, Sun X, Schmidt C, Pamir N, Özduman K, Herold-Mende C, Pagani F, Cominelli M, Taranda J, Wick W, von Deimling A, Poliani PL, Rehli M, Schlesner M, Heyn H, Turcan Ş
Cell reports. Medicine 2023 Nov 21;4(11):101249
Cell reports. Medicine 2023 Nov 21;4(11):101249
Microglial targeted therapy relieves cognitive impairment caused by Cntnap4 deficiency.
Zhang W, Chen H, Ding L, Huang J, Zhang M, Liu Y, Ma R, Zheng S, Gong J, Piña-Crespo JC, Zhang Y
Exploration (Beijing, China) 2023 Jun;3(3):20220160
Exploration (Beijing, China) 2023 Jun;3(3):20220160
Inhibition of inflammation and infiltration of M2 macrophages in NSCLC through the ATF3/CSF1 axis: Role of miR-27a-3p.
Zhou B, Xu Y, Xu L, Kong Y, Li K, Chen B, Li J
International journal of experimental pathology 2023 Dec;104(6):292-303
International journal of experimental pathology 2023 Dec;104(6):292-303
Human placenta-based genome-wide mRNA sequencing to identify TEK/IGF1/CSF1/ANGPT2 as crucial segments in the pathogenesis of pre-eclampsia.
Wang L, Zhang L, Fan Y, Peng Y, Song D, Fu J, Wang X
Frontiers in genetics 2022;13:944932
Frontiers in genetics 2022;13:944932
Polarization and β-Glucan Reprogram Immunomodulatory Metabolism in Human Macrophages and Ex Vivo in Human Lung Cancer Tissues.
Fan TW, Daneshmandi S, Cassel TA, Uddin MB, Sledziona J, Thompson PT, Lin P, Higashi RM, Lane AN
Journal of immunology (Baltimore, Md. : 1950) 2022 Nov 1;209(9):1674-1690
Journal of immunology (Baltimore, Md. : 1950) 2022 Nov 1;209(9):1674-1690
A novel chemokine-based signature for prediction of prognosis and therapeutic response in glioma.
Fan W, Wang D, Li G, Xu J, Ren C, Sun Z, Wang Z, Ma W, Zhao Z, Bao Z, Jiang T, Zhang Y
CNS neuroscience & therapeutics 2022 Dec;28(12):2090-2103
CNS neuroscience & therapeutics 2022 Dec;28(12):2090-2103
Targeting CSF1R Alone or in Combination with PD1 in Experimental Glioma.
Przystal JM, Becker H, Canjuga D, Tsiami F, Anderle N, Keller AL, Pohl A, Ries CH, Schmittnaegel M, Korinetska N, Koch M, Schittenhelm J, Tatagiba M, Schmees C, Beck SC, Tabatabai G
Cancers 2021 May 15;13(10)
Cancers 2021 May 15;13(10)
Integrating transcriptome-wide study and mRNA expression profiles yields novel insights into the biological mechanism of chondropathies.
Li P, Ning Y, Guo X, Wen Y, Cheng B, Ma M, Zhang L, Cheng S, Wang S, Zhang F
Arthritis research & therapy 2019 Aug 27;21(1):194
Arthritis research & therapy 2019 Aug 27;21(1):194
No comments: Submit comment
No validations: Submit validation data